News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Wyeth (JOBS) Won’t Market Sleeplessness Treatment
January 19, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Forbes -- Vaccine maker Wyeth, a subsidiary of Pfizer Inc., the world's biggest drugmaker, will not market Ibuprofen/Diphenhydramine Hydrochloride in Europe after dissapointing data. The drug was intended to treat sleeplessness caused by pain.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
Vaccines
FDA Clears Updated COVID-19 Shots From Pfizer, Moderna, Novavax—But With Restrictions
August 28, 2025
·
2 min read
·
Tristan Manalac
Policy
Monarez Fired From Top CDC Spot Following Friction Over New COVID-19 Vaccine Policy
August 28, 2025
·
3 min read
·
Heather McKenzie
Regulatory
The US Is Losing Its Biopharma Edge, Writes Former FDA Commissioner
August 27, 2025
·
3 min read
·
Dan Samorodnitsky
Rare diseases
Regeneron Eyes 2026 Filing for siRNA Myasthenia Gravis Drug After Phase III Win
August 27, 2025
·
2 min read
·
Tristan Manalac